Catalog No.: PC-26826Not For Human Use, Lab Use Only.
Cetrimonium bromide (CetB) is a specific small-molecule inhibitor of Epstein-Barr virus (EBV) latently infected cancer cells, reduces EBNA1 protein stability, activates G1 arrest and early apoptosis of EBV-latently infected cells without viral lytic reactivation, modulates canonical and non-canonical TGF-β signaling pathways, inhibits cancer cell migration and invasion.
Cetrimonium bromide (CetB) is a specific small-molecule inhibitor of Epstein-Barr virus (EBV) latently infected cancer cells, reduces EBNA1 protein stability, activates G1 arrest and early apoptosis of EBV-latently infected cells without viral lytic reactivation, modulates canonical and non-canonical TGF-β signaling pathways, inhibits cancer cell migration and invasion.
Physicochemical Properties
M.Wt
364.46
Formula
C19H42BrN
Appearance
Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility
10 mM in DMSO
Chemical Name/SMILES
N,N,N-Trimethylhexadecan-1-aminium bromide
References
1. Li Y, et al. iScience. 2024 Jul 25;27(9):110581.
2. Wu T K, et al. Anticancer Research, 2019, 39(7): 3621-3631.
